Clinical trials: Plasma Concentration

Plasma Concentrations

Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTab

• Completed
• Age: 18 to 45 years
• Phase 1
• Results posted

Determine the plasma concentration profile after single and multiple dosing of Sufentanil NanoTabs

Trial name

NCT01761565

Testing

Single dose of SUF NT 15 mcg, 40 consecutive doses of SUF NT 15 mcg taken every 20 minutes

Where

United States

Volunteers

40 people, healthy volunteers welcome

Sponsor

Talphera, Inc